Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: PDT

Arcadia Stresses the Importance of Distance Learning in the Pandemic Environment

LONDON, March 27, 2020 /PRNewswire/ -- During these uncertain times, people all around the world are encouraged or required to work from home. Similarly, with schools being widely closed for safety reasons, students alike are required to work in remote mode using distance learning platforms.

The trend is growing as seen just last week when education technology providers in Finland started offering free educational tools for distance learning amidst the COVID-19 epidemic.

Arcadia is a proven leader in e-learning and digital assessments solutions, designing and building custom virtual learning environments used in all level of education, from primary schools to universities.

"Arcadia's digital tools are supporting distance learning for all ages. We work with world's leading learning platform providers with the aim of helping to produce engaging and valuable apps that benefit both the teachers and the students" explains Dmitri Adov, Technical Director at Arcadia.

Some of our work includes improving current education technology platforms by scaling up the performance to accommodate a growing number of users, providing responsive web design to enable usage on mobile devices and incorporating collaboration tools that support the communication between teachers and students.

With home schooling and distance learning the challenge is often to keep users engaged and motivated so the addition of digital tools such as internal chats, video chats and discussion boards is an easy but effective way to maintain successful learning and top of the line results. We also build in accessibility features as required by Web Content Accessibility Guidelines 2.0 AA level both in Europe and in the UK, for all people with disabilities so nobody gets left behind.

The visual reporting tools we design and build make sure that teachers have access to instant easy to digest snapshots of students performance and frees them from labour intensive manual analysis."

Studying from home is now the norm that e-learning web solutions are well placed to facilitate.  

Arcadia, a multi-million pound British Standards Institute (BSI) certified company that works extensively with Fortune 500 companies designing and building high-load web solutions for digitisation, analytics, big data, reporting and AI, integrated with core business software, provides the full range of software development services across sectors from education to pharmaceuticals and from retail to airlines.

For more information about Arcadia, contact
Dmitri Adov, Technical Director        

These press releases may also interest you

at 11:23
Today, Samaritan's Purse deployed its Emergency Field Hospital to New York City, New York, where the local medical infrastructure is severely overwhelmed. In cooperation with the Federal Emergency Management Agency (FEMA), New York state officials,...

at 11:01
Novartis today announced results from a prespecified analysis of pooled data from three Phase III studies evaluating the safety and efficacy of inclisiran, its first-in-class investigational treatment for hyperlipidemia in adults. The data was...

at 11:00
As the impact of the Coronavirus (COVID-19) is now felt worldwide, we want to assure our customers and partners that we are still here to support you. Zenner's operations remain open with regular operating hours. Zenner's number one priority is...

at 10:13
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg...

at 10:05
Merck , known as MSD outside the United States and Canada, today announced the presentation of results from the VICTORIA trial, a Phase 3 study evaluating the efficacy and safety of its investigational drug vericiguat, an orally administered soluble...

at 10:00
Amgen today announced positive results from the EvolocumaB Effect on LDL-C LowerIng in SubJEcts with Human Immunodeficiency ViRus and INcreased Cardiovascular RisK (BEIJERINCK) study evaluating the efficacy and safety of Repatha® (evolocumab) in...

News published on 27 march 2020 at 03:00 and distributed by: